Volume 6, Issue 2 (2020)                   Pharm Biomed Res 2020, 6(2): 143-150 | Back to browse issues page


XML Print


1- Department of Pharmacy, University of Asia Pacific, 74/A Green Road, Farmgate, Dhaka-1205, Bangladesh.
Abstract:   (1437 Views)
Background: Studies of the pharmacotherapeutic pattern on schizophrenic patients are few Clinical therapy is one of the bases for the assessment of the treatment of schizophrenia.
Objectives: This study aimed to analyze the demographics of schizophrenic patients along with current trends of drug prescribing practice in Bangladesh.
Methods: This survey was conducted over 6 months at the National Institute of Mental Health, Dhaka, Bangladesh, and Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh. A total of 250 subjects were investigated and their prescriptions were verified to obtain necessary information regarding pharmacotherapy. Non-cooperation and negative consent lead to exclusion from the study sample.
Results: Out of 250 patients, the frequency of female patients was higher (54.4%) than that of the male patients (45.6%). Therefore, the gender ratio was female-biased. We found that 63.6% of the patients suffering from schizophrenia were above 25 years old. The treatment approach of schizophrenia includes pharmacotherapy and or psychotherapy. In this study, we found that the highest medication used in the treatment was antipsychotic drugs (n=388, 46.58%) followed by anticholinergic drugs (n=217, 26.05%) and anxiolytic drugs (n=172, 20.65%).
Conclusion: The overall prescribing method for schizophrenia in Bangladesh complies with the authorized practiced guidelines and treatment pattern of the developed countries as well as authorized guidelines.
Full-Text [PDF 705 kb]   (936 Downloads) |   |   Full-Text (HTML)  (1330 Views)  
Type of Study: Original Research | Subject: Rational Drug Prescribing

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.